Literature DB >> 14641406

Research criteria versus clinical criteria for interstitial cystitis.

Christopher K Payne1, Akito Terai, Kazuto Komatsu.   

Abstract

In March 2003 experts on interstitial cystitis (IC) from around the world met in Kyoto, Japan for a series of workshops intended to define areas of agreement and difference in the approach to this disease. This workshop explored the diagnostic criteria IC in the clinical and research settings. The NIDDK criteria are used almost universally for research but there is tremendous disparity in the clinics and no consensus at all as to the best practice in diagnosing IC for clinical purposes. Throughout the world many physicians use the NIDDK research criteria for clinical diagnosis; in some countries this is standard. Undoubtedly, this mandates under-diagnosis and denies treatment to many patients. Still, a majority feel that one diagnostic system is mandatory to promote clarity in communication. The group called for two initiatives to help advance this area of controversy: (1) a large-scale, prospective study critically examining the role of cystoscopy, bladder distention, and biopsy in the diagnosis of IC; (2) a concerted effort to develop a single evidence-based guideline or algorithm that would be flexible enough to meet the needs of clinicians, researchers, and patients.

Entities:  

Mesh:

Year:  2003        PMID: 14641406     DOI: 10.1046/j.1442-2042.10.s1.3.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  10 in total

1.  Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women.

Authors:  John W Warren; Jessica Brown; J Kathleen Tracy; Patricia Langenberg; Ursula Wesselmann; Patty Greenberg
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

Review 2.  [Interstitial cystitis. An important differential diagnosis].

Authors:  A van Ophoven; F Oberpenning
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

Review 3.  Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.

Authors:  Jason Sea; Joel M H Teichman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

Authors:  Abhishek Seth; Joel M H Teichman
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

6.  Office bladder distention with electromotive drug administration (EMDA) is equivalent to distention under general anesthesia (GA).

Authors:  Amy E Rose; Kathryn J Azevedo; Christopher K Payne
Journal:  BMC Urol       Date:  2005-11-22       Impact factor: 2.264

7.  Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders.

Authors:  Gaurav Mukerji; Janet Waters; Iain P Chessell; Chas Bountra; Sanjiv K Agarwal; Praveen Anand
Journal:  BMC Urol       Date:  2006-12-27       Impact factor: 2.264

8.  Increased Expression of Neuregulin 1 and erbB2 Tyrosine Kinase in the Bladder of Rats With Cyclophosphamide-Induced Interstitial Cystitis.

Authors:  Ki Hak Song; Chang Shik Youn; Chung Lyul Lee; Seung Woo Yang; Young Seop Chang; Seoung Woo Jeong; Chong Koo Sul
Journal:  Int Neurourol J       Date:  2015-09-22       Impact factor: 2.835

9.  Unsupervised Machine Learning Approaches Reveal Distinct Phenotypes of Perceived Bladder Pain: A Pilot Study.

Authors:  Patricia J Mwesigwa; Nicholas J Jackson; Ashley T Caron; Falisha Kanji; James E Ackerman; Jessica R Webb; Victoria C S Scott; Karyn S Eilber; David M Underhill; Jennifer T Anger; A Lenore Ackerman
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-05

10.  Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations.

Authors:  Gaurav Mukerji; Yiangos Yiangou; Stacey L Corcoran; Inger S Selmer; Graham D Smith; Christopher D Benham; Chas Bountra; Sanjiv K Agarwal; Praveen Anand
Journal:  BMC Urol       Date:  2006-03-06       Impact factor: 2.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.